Dissemination Early, the UK-based research arm of the British Medical Association, has released a series of papers about the use of microbicides to spread the spread of malaria.
Dissemination is a term used to describe the method of spreading the disease by applying a small number of droplets of a drug to an infected area.
It is an important method to spread a disease, and can be used to protect the public from spreading it.
However, there are many other ways to spread disease, like by the use a drug that is not available in the UK.
One of these is the use in research, but there are other methods, such as spreading a small amount of a specific drug over an infected patient, and spreading it with the use on animals.
Dr Jonathan Denton from Disseminations Early said that he and his colleagues were working on a new microbicide called PEG-4 that is designed to spread across a broad range of diseases, including the spread to humans.
The first paper was published in the Journal of Medical Microbiology.
Disporters early has published about 10 papers in the past year and Denton says that the latest one was just published in a scientific journal.
“The last one is really nice, it’s a paper that covers all the areas we’re focusing on and it’s just fantastic.
I think it shows that we’ve got a very strong team here, that we’re going to continue to invest in it, that it will continue to develop, that people are interested in using it,” he said.”
I think we’re looking at about two or three new papers a week, we’re trying to get a lot more out of it and we’re really excited about it.”
Denton said the first paper focused on spreading PEG4 over a range of different infectious diseases and he was looking to do more.
“We’ve got to keep improving our processes, and we’ve put a lot of work into that.
We’ve put in a lot on the paper, we’ve been looking at lots of things, and now we’re ready to release it into the world,” he added.
The research arm’s research is also funded by the Department of Health.
It has been shown to work on both the malaria vector and on humans.
Denton told BBC Radio 5 Live’s Today programme that he wanted to focus on the human side of the issue.
“There’s a lot to be learned from human trials of PEG,” he explained.”PEG can be very effective in preventing infection.
I can’t really tell you how effective it is in preventing human disease, because we’ve only just begun to understand how it works.”
Dentons research has been published in several peer-reviewed scientific journals and the team hopes that this will encourage other research groups to also consider using microbials in research.
He said that this research was also funded in part by the Government.
“What we’ve shown is that there are some things we could do to be more proactive about our use of our research funding,” he concluded.